[HTML][HTML] Metabolomics in antimicrobial drug discovery

R Aminov - Expert Opinion on Drug Discovery, 2022 - Taylor & Francis
Introduction In light of the ever-escalating problem of antimicrobial resistance, there is an
urgent need for the development of new antimicrobials. In this review, the role of …

[HTML][HTML] The pharmacokinetic–pharmacodynamic modelling framework as a tool to predict drug resistance evolution

C Witzany, J Rolff, RR Regoes, C Igler - Microbiology, 2023 - microbiologyresearch.org
Pharmacokinetic–pharmacodynamic (PKPD) models, which describe how drug
concentrations change over time and how that affects pathogen growth, have proven highly …

[HTML][HTML] Multi-step vs. single-step resistance evolution under different drugs, pharmacokinetics, and treatment regimens

C Igler, J Rolff, R Regoes - elife, 2021 - elifesciences.org
The success of antimicrobial treatment is threatened by the evolution of drug resistance.
Population genetic models are an important tool in mitigating that threat. However, most …

A guide to enzyme kinetics in early drug discovery

B Srinivasan - The FEBS Journal, 2023 - Wiley Online Library
Drugs interact with their target of interest to bring about the desired phenotypic outcome that
results in disease alleviation. Traditionally, most lead optimization exercises were driven by …

[HTML][HTML] Slow-binding reversible inhibitor of acetylcholinesterase with long-lasting action for prophylaxis of organophosphate poisoning

OA Lenina, IV Zueva, VV Zobov, VE Semenov… - Scientific Reports, 2020 - nature.com
Organophosphorus (OP) compounds represent a serious health hazard worldwide. The
dominant mechanism of their action results from covalent inhibition of acetylcholinesterase …

Assessing the relative importance of bacterial resistance, persistence and hyper-mutation for antibiotic treatment failure

C Witzany, RR Regoes, C Igler - Proceedings of the …, 2022 - royalsocietypublishing.org
To curb the rising threat of antimicrobial resistance, we need to understand the routes to
antimicrobial treatment failure. Bacteria can survive treatment by using both genetic and …

[HTML][HTML] Perspectives for systems biology in the management of tuberculosis

I Kontsevaya, C Lange… - European …, 2021 - Eur Respiratory Soc
Standardised management of tuberculosis may soon be replaced by individualised,
precision medicine-guided therapies informed with knowledge provided by the field of …

Semi-quantitatively predicting the residence time of three natural products on endothelin receptor A by peak profiling using the receptor functionalized macroporous …

P Li, B Shi, L Li, J Yin, Q Yao, T Yang, X Huang… - Journal of Analysis and …, 2023 - Springer
Drug–receptor interaction analysis has been broadly adopted as a tool for the evaluation of
the drug-like property. Nowadays, growing evidence has demonstrated that drug efficacy …

Systems biology: current status and challenges

A Zupanic, HC Bernstein, I Heiland - Cellular and Molecular Life Sciences, 2020 - Springer
We put together a special issue on current approaches in systems biology with a focus on
mathematical modeling of metabolic networks. Mathematical models have increasingly been …

[HTML][HTML] Current experimental methods to investigate the impact of specialized pro-resolving lipid mediators on Sjögren's syndrome

HT Dos Santos, K Nam, D Gil, V Yellepeddi… - Frontiers in …, 2023 - frontiersin.org
Sjögren's syndrome is a chronic inflammatory autoimmune disease characterized by
diminished secretory function of the exocrine glands. Although extensive investigation has …